French pharmaceutical company BPI has signed a SR375 million ($100 million) agreement to establish its first manufacturing base in Saudi Arabia, securing a site in Sudair City for Industry and Business.
The deal, signed with the Saudi Authority for Industrial Cities and Technology Zones (MODON) under the patronage of Industry and Mineral Resources Minister Bandar Alkhorayef, covers over 51,000 sq. meters. MODON CEO Majid bin Rafid Al-Arqoubi attended the signing, according to SPA.
BPI’s facilities will produce pharmaceuticals for human and veterinary use, medicinal herbs, surgical dressings, chemical sugar, and blood sugar monitoring devices.
The investment aligns with Vision 2030 and the National Industrial Strategy, aiming to position the Kingdom as a regional hub for biomanufacturing and medical innovation.
In a separate initiative, MODON signed an agreement with Asas and Takween Information Technology to establish a Center of Excellence for Artificial Intelligence. The project will streamline processes, boost efficiency, and foster AI-driven innovation across the industrial sector.